Cargando…

Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians

BACKGROUND: Pharmacogenetics targets genetic variations that influence drug response. It is relatively a new science that has not been vastly employed in most developing countries including Syria. Therefore we aimed at evaluating the depth of knowledge in pharmacogenetics and the attitude towards it...

Descripción completa

Detalles Bibliográficos
Autores principales: Albitar, Lina, Alchamat, Ghalia Abou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485485/
https://www.ncbi.nlm.nih.gov/pubmed/34592972
http://dx.doi.org/10.1186/s12913-021-07040-9
_version_ 1784577545628286976
author Albitar, Lina
Alchamat, Ghalia Abou
author_facet Albitar, Lina
Alchamat, Ghalia Abou
author_sort Albitar, Lina
collection PubMed
description BACKGROUND: Pharmacogenetics targets genetic variations that influence drug response. It is relatively a new science that has not been vastly employed in most developing countries including Syria. Therefore we aimed at evaluating the depth of knowledge in pharmacogenetics and the attitude towards it amongst Syrian pharmacists and physicians. METHODS: We carried out an internet-based questionnaire consisted of 26 questions, sent through specialized websites and private groups with a large number of pharmacists and physicians members. The survey was available online for a period of 1 month. RESULTS: The total number of respondents was 154, mostly female pharmacists. Our statistical analysis showed a strong positive association between profession (in favour of pharmacists) and pharmacogenetics knowledge p = 0.049; however, no correlation with experience p = 0.811 was found. A significant difference was reported between the knowledge of pharmacists and physicians p = 0.001 concerning drugs that need pharmacogenetics testing before being prescribed. The majority of respondents had no information about applying genetic tests in Syria before prescribing medications nor did they possess the knowledge regarding drugs that show differential responses in patients according to their unique genotypes. In our study, the percentage knowledge assessment score was low in general (mean ± Standard deviation, SD) (46% ± 13.9%). The majority of the respondents agreed that pharmacists should provide counselling to patients on the subject of pharmacogenetics. Respondents’ opinions varied concerning making pharmacogenetics learning a priority. CONCLUSION: Lack of pharmacogenetics knowledge was found amongst respondents in general. Our findings raise concerns about the lack of awareness amongst physicians, which may hinder the implementation of this crucial field in Syria. We suggest an emphasis on the role of education, training, and conducting genotyping research on the Syrian population. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-021-07040-9.
format Online
Article
Text
id pubmed-8485485
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-84854852021-10-04 Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians Albitar, Lina Alchamat, Ghalia Abou BMC Health Serv Res Research BACKGROUND: Pharmacogenetics targets genetic variations that influence drug response. It is relatively a new science that has not been vastly employed in most developing countries including Syria. Therefore we aimed at evaluating the depth of knowledge in pharmacogenetics and the attitude towards it amongst Syrian pharmacists and physicians. METHODS: We carried out an internet-based questionnaire consisted of 26 questions, sent through specialized websites and private groups with a large number of pharmacists and physicians members. The survey was available online for a period of 1 month. RESULTS: The total number of respondents was 154, mostly female pharmacists. Our statistical analysis showed a strong positive association between profession (in favour of pharmacists) and pharmacogenetics knowledge p = 0.049; however, no correlation with experience p = 0.811 was found. A significant difference was reported between the knowledge of pharmacists and physicians p = 0.001 concerning drugs that need pharmacogenetics testing before being prescribed. The majority of respondents had no information about applying genetic tests in Syria before prescribing medications nor did they possess the knowledge regarding drugs that show differential responses in patients according to their unique genotypes. In our study, the percentage knowledge assessment score was low in general (mean ± Standard deviation, SD) (46% ± 13.9%). The majority of the respondents agreed that pharmacists should provide counselling to patients on the subject of pharmacogenetics. Respondents’ opinions varied concerning making pharmacogenetics learning a priority. CONCLUSION: Lack of pharmacogenetics knowledge was found amongst respondents in general. Our findings raise concerns about the lack of awareness amongst physicians, which may hinder the implementation of this crucial field in Syria. We suggest an emphasis on the role of education, training, and conducting genotyping research on the Syrian population. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12913-021-07040-9. BioMed Central 2021-10-01 /pmc/articles/PMC8485485/ /pubmed/34592972 http://dx.doi.org/10.1186/s12913-021-07040-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Albitar, Lina
Alchamat, Ghalia Abou
Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians
title Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians
title_full Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians
title_fullStr Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians
title_full_unstemmed Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians
title_short Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians
title_sort pharmacogenetics: knowledge assessment amongst syrian pharmacists and physicians
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8485485/
https://www.ncbi.nlm.nih.gov/pubmed/34592972
http://dx.doi.org/10.1186/s12913-021-07040-9
work_keys_str_mv AT albitarlina pharmacogeneticsknowledgeassessmentamongstsyrianpharmacistsandphysicians
AT alchamatghaliaabou pharmacogeneticsknowledgeassessmentamongstsyrianpharmacistsandphysicians